Given that the differential NANOG methylation pattern in cancer cell lines can be a consequence of in vitro culturing rather than association with their tumorigenicity per se, we, therefore, investigated NANOG promoter methylation in primary HCC tumors paired with adjacent non-tumor tissues (n = 15), compared to normal liver samples (Figure 3A). The gene discussed is NANOG; the disease is hepatocellular carcinoma.